SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-039388
Filing Date
2023-08-08
Accepted
2023-08-08 08:14:38
Documents
102
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q hznp-20230630.htm   iXBRL 10-Q 5119356
2 EX-10.1 hznp-ex10_1.htm EX-10.1 11381
3 EX-10.2 hznp-ex10_2.htm EX-10.2 1256782
4 EX-31.1 hznp-ex31_1.htm EX-31.1 12631
5 EX-31.2 hznp-ex31_2.htm EX-31.2 12910
6 EX-32.1 hznp-ex32_1.htm EX-32.1 10798
7 EX-32.2 hznp-ex32_2.htm EX-32.2 10708
  Complete submission text file 0000950170-23-039388.txt   18770777

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT hznp-20230630_cal.xml EX-101.CAL 69944
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT hznp-20230630_lab.xml EX-101.LAB 701212
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT hznp-20230630_def.xml EX-101.DEF 348774
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hznp-20230630_pre.xml EX-101.PRE 565345
12 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hznp-20230630.xsd EX-101.SCH 97033
96 EXTRACTED XBRL INSTANCE DOCUMENT hznp-20230630_htm.xml XML 3674433
Mailing Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4
Business Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4 011-353-1-772-2100
Horizon Therapeutics Public Ltd Co (Filer) CIK: 0001492426 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35238 | Film No.: 231149452
SIC: 2834 Pharmaceutical Preparations